Why won’t Australia run medical trials of MDMA?


If you’ve taken MDMA (usually the active ingredient in ecstasy) you’ll know the euphoria and hugging and evangelical sense of “if everyone tried this, we could save the WORLD.” Well, some people take that evangelism very seriously, or at least in a medical sense. Last year VICE reported on trials that were about to start in Canada to test MDMA on people suffering Post Traumatic Stress Disorder (PTSD), and while trials in other parts of the world have been undertaken or are underway, Australia has so far refused to get involved. To find out why, I spoke to Martin Williams from Psychedelic Research in Science & Medicine (prism.org.au), an Australian organisation trying to run the first such local trial, and asked him why we need to reframe the ecstatic experience in Australia.

Read more here: http://www.vice.com/en_au/read/why-wont-australia-run-medical-trials-of-mdma

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search